Listed

Collegium Pharmaceutical, Inc

COLLNasdaqCIK 1267565HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$199.9m, Q2 FY2026
Operating income$3.7m, Q2 FY2026
Net income−$15.1m, Q2 FY2026
Collegium Pharmaceutical, Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m137Revenue, Q3 FY2023, three months to 2023-09-30$136.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure150Revenue, Q4 FY2023, three months to 2023-12-31$149.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure145Revenue, Q1 FY2024, three months to 2024-03-31$144.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure145Revenue, Q2 FY2024, three months to 2024-06-30$145.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure159Revenue, Q3 FY2024, three months to 2024-09-30$159.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure182Revenue, Q4 FY2024, three months to 2024-12-31$181.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure178Revenue, Q1 FY2025, three months to 2025-03-31$177.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure188Revenue, Q2 FY2025, three months to 2025-06-30$188.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure209Revenue, Q3 FY2025, three months to 2025-09-30$209.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure205Revenue, Q4 FY2025, three months to 2025-12-31$205.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure194Revenue, Q1 FY2026, three months to 2026-03-31$193.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure200Revenue, Q2 FY2026, three months to 2026-06-30$199.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Cost of revenue$m56.4Cost of revenue, Q3 FY2023, three months to 2023-09-30$56.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure55.1Cost of revenue, Q4 FY2023, three months to 2023-12-31$55.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure53.5Cost of revenue, Q1 FY2024, three months to 2024-03-31$53.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure54.5Cost of revenue, Q2 FY2024, three months to 2024-06-30$54.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure62.5Cost of revenue, Q3 FY2024, three months to 2024-09-30$62.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure83.7Cost of revenue, Q4 FY2024, three months to 2024-12-31$83.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure80.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$80.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure79.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$79.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure80.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$80.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure77.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$77.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure76.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$76.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure89.6Cost of revenue, Q2 FY2026, three months to 2026-06-30$89.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Gross profit$m80.3Gross profit, Q3 FY2023, three months to 2023-09-30$80.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure94.6Gross profit, Q4 FY2023, three months to 2023-12-31$94.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure91.5Gross profit, Q1 FY2024, three months to 2024-03-31$91.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure90.8Gross profit, Q2 FY2024, three months to 2024-06-30$90.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure96.8Gross profit, Q3 FY2024, three months to 2024-09-30$96.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure98.3Gross profit, Q4 FY2024, three months to 2024-12-31$98.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure97.3Gross profit, Q1 FY2025, three months to 2025-03-31$97.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure108Gross profit, Q2 FY2025, three months to 2025-06-30$108.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure129Gross profit, Q3 FY2025, three months to 2025-09-30$129.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure128Gross profit, Q4 FY2025, three months to 2025-12-31$128.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure117Gross profit, Q1 FY2026, three months to 2026-03-31$117.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure110Gross profit, Q2 FY2026, three months to 2026-06-30$110.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m35.3Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$35.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure32.9Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$32.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure42.0Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$42.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure43.3Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$43.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure62.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$62.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure63.1Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$63.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure76.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$76.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure73.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$73.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure67.1Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$67.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure67.6Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$67.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure86.4Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$86.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure107Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$106.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Operating income$m45.0Operating income, Q3 FY2023, three months to 2023-09-30$45.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure61.7Operating income, Q4 FY2023, three months to 2023-12-31$61.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure49.5Operating income, Q1 FY2024, three months to 2024-03-31$49.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure47.5Operating income, Q2 FY2024, three months to 2024-06-30$47.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure34.8Operating income, Q3 FY2024, three months to 2024-09-30$34.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure38.1Operating income, Q4 FY2024, three months to 2024-12-31$38.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure21.7Operating income, Q1 FY2025, three months to 2025-03-31$21.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure35.1Operating income, Q2 FY2025, three months to 2025-06-30$35.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure62.1Operating income, Q3 FY2025, three months to 2025-09-30$62.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure60.8Operating income, Q4 FY2025, three months to 2025-12-31$60.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure30.9Operating income, Q1 FY2026, three months to 2026-03-31$30.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure3.7Operating income, Q2 FY2026, three months to 2026-06-30$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Interest expense$m20.8Interest expense, Q3 FY2023, three months to 2023-09-30$20.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-22, accession 0001558370-24-001526.Report this figure19.3Interest expense, Q4 FY2023, three months to 2023-12-31$19.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-22, accession 0001558370-24-001526.Report this figure17.3Interest expense, Q1 FY2024, three months to 2024-03-31$17.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001558370-24-007601.Report this figure15.6Interest expense, Q2 FY2024, three months to 2024-06-30$15.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure18.4Interest expense, Q3 FY2024, three months to 2024-09-30$18.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure22.7Interest expense, Q4 FY2024, three months to 2024-12-31$22.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure20.8Interest expense, Q1 FY2025, three months to 2025-03-31$20.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure20.5Interest expense, Q2 FY2025, three months to 2025-06-30$20.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure21.8Interest expense, Q3 FY2025, three months to 2025-09-30$21.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure19.3Interest expense, Q4 FY2025, three months to 2025-12-31$19.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure15.9Interest expense, Q1 FY2026, three months to 2026-03-31$15.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure19.5Interest expense, Q2 FY2026, three months to 2026-06-30$19.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Income tax$m8.1Income tax, Q3 FY2023, three months to 2023-09-30$8.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure14.8Income tax, Q4 FY2023, three months to 2023-12-31$14.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure8.9Income tax, Q1 FY2024, three months to 2024-03-31$8.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure9.5Income tax, Q2 FY2024, three months to 2024-06-30$9.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure6.2Income tax, Q3 FY2024, three months to 2024-09-30$6.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure4.7Income tax, Q4 FY2024, three months to 2024-12-31$4.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.7Income tax, Q1 FY2025, three months to 2025-03-31$705.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure5.0Income tax, Q2 FY2025, three months to 2025-06-30$5.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure11.9Income tax, Q3 FY2025, three months to 2025-09-30$11.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure12.1Income tax, Q4 FY2025, three months to 2025-12-31$12.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure4.2Income tax, Q1 FY2026, three months to 2026-03-31$4.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure1.5Income tax, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Net income$m20.6Net income, Q3 FY2023, three months to 2023-09-30$20.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure31.9Net income, Q4 FY2023, three months to 2023-12-31$31.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure27.7Net income, Q1 FY2024, three months to 2024-03-31$27.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure19.6Net income, Q2 FY2024, three months to 2024-06-30$19.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure9.3Net income, Q3 FY2024, three months to 2024-09-30$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure12.5Net income, Q4 FY2024, three months to 2024-12-31$12.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure2.4Net income, Q1 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure12.0Net income, Q2 FY2025, three months to 2025-06-30$12.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure31.5Net income, Q3 FY2025, three months to 2025-09-30$31.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure17.0Net income, Q4 FY2025, three months to 2025-12-31$17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure14.5Net income, Q1 FY2026, three months to 2026-03-31$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure(15.1)Net income, Q2 FY2026, three months to 2026-06-30−$15.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Diluted EPS$ per share0.53Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure0.82Diluted EPS, Q4 FY2023, three months to 2023-12-31$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure0.71Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.52Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.27Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.36Diluted EPS, Q4 FY2024, three months to 2024-12-31$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.07Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure0.34Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure0.84Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.46Diluted EPS, Q4 FY2025, three months to 2025-12-31$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.40Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure(0.46)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Basic EPS$ per share0.61Basic EPS, Q3 FY2023, three months to 2023-09-30$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure0.99Basic EPS, Q4 FY2023, three months to 2023-12-31$0.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure0.86Basic EPS, Q1 FY2024, three months to 2024-03-31$0.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.60Basic EPS, Q2 FY2024, three months to 2024-06-30$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.29Basic EPS, Q3 FY2024, three months to 2024-09-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.39Basic EPS, Q4 FY2024, three months to 2024-12-31$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.08Basic EPS, Q1 FY2025, three months to 2025-03-31$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure0.38Basic EPS, Q2 FY2025, three months to 2025-06-30$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure1.00Basic EPS, Q3 FY2025, three months to 2025-09-30$1.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.54Basic EPS, Q4 FY2025, three months to 2025-12-31$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure0.45Basic EPS, Q1 FY2026, three months to 2026-03-31$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure(0.46)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure

Balance sheet

Cash and equivalents$129.5m, Q2 FY2026
Shareholders' equity$311.9m, Q2 FY2026
Collegium Pharmaceutical, Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m259Cash and equivalents, Q3 FY2023, at 2023-09-30$258.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001558370-24-014858.Report this figure239Cash and equivalents, FY2023, at 2023-12-31$238.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure229Cash and equivalents, Q1 FY2024, at 2024-03-31$228.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001558370-25-006960.Report this figure173Cash and equivalents, Q2 FY2024, at 2024-06-30$172.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001558370-25-010649.Report this figure39.0Cash and equivalents, Q3 FY2024, at 2024-09-30$39.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure70.6Cash and equivalents, FY2024, at 2024-12-31$70.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure96.2Cash and equivalents, Q1 FY2025, at 2025-03-31$96.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure117Cash and equivalents, Q2 FY2025, at 2025-06-30$117.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure150Cash and equivalents, Q3 FY2025, at 2025-09-30$150.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure231Cash and equivalents, FY2025, at 2025-12-31$231.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure269Cash and equivalents, Q1 FY2026, at 2026-03-31$268.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure129Cash and equivalents, Q2 FY2026, at 2026-06-30$129.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Current assets$m537Current assets, Q3 FY2023, at 2023-09-30$537.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001558370-23-017983.Report this figure538Current assets, FY2023, at 2023-12-31$537.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure539Current assets, Q1 FY2024, at 2024-03-31$539.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007601.Report this figure510Current assets, Q2 FY2024, at 2024-06-30$510.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011586.Report this figure444Current assets, Q3 FY2024, at 2024-09-30$443.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014858.Report this figure482Current assets, FY2024, at 2024-12-31$482.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure528Current assets, Q1 FY2025, at 2025-03-31$527.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001558370-25-006960.Report this figure549Current assets, Q2 FY2025, at 2025-06-30$549.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001558370-25-010649.Report this figure614Current assets, Q3 FY2025, at 2025-09-30$613.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure691Current assets, FY2025, at 2025-12-31$691.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure746Current assets, Q1 FY2026, at 2026-03-31$745.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure608Current assets, Q2 FY2026, at 2026-06-30$608.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Total assets$m1,178Total assets, Q3 FY2023, at 2023-09-30$1.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001558370-23-017983.Report this figure1,143Total assets, FY2023, at 2023-12-31$1.14bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure1,114Total assets, Q1 FY2024, at 2024-03-31$1.11bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001558370-24-007601.Report this figure1,053Total assets, Q2 FY2024, at 2024-06-30$1.05bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001558370-24-011586.Report this figure1,635Total assets, Q3 FY2024, at 2024-09-30$1.64bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001558370-24-014858.Report this figure1,664Total assets, FY2024, at 2024-12-31$1.66bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure1,631Total assets, Q1 FY2025, at 2025-03-31$1.63bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001558370-25-006960.Report this figure1,593Total assets, Q2 FY2025, at 2025-06-30$1.59bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001558370-25-010649.Report this figure1,607Total assets, Q3 FY2025, at 2025-09-30$1.61bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure1,657Total assets, FY2025, at 2025-12-31$1.66bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure1,652Total assets, Q1 FY2026, at 2026-03-31$1.65bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure2,136Total assets, Q2 FY2026, at 2026-06-30$2.14bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Current liabilities$m465Current liabilities, Q3 FY2023, at 2023-09-30$464.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001558370-23-017983.Report this figure458Current liabilities, FY2023, at 2023-12-31$457.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure446Current liabilities, Q1 FY2024, at 2024-03-31$446.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007601.Report this figure462Current liabilities, Q2 FY2024, at 2024-06-30$461.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011586.Report this figure459Current liabilities, Q3 FY2024, at 2024-09-30$459.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014858.Report this figure510Current liabilities, FY2024, at 2024-12-31$509.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure487Current liabilities, Q1 FY2025, at 2025-03-31$486.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001558370-25-006960.Report this figure465Current liabilities, Q2 FY2025, at 2025-06-30$464.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001558370-25-010649.Report this figure453Current liabilities, Q3 FY2025, at 2025-09-30$452.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure440Current liabilities, FY2025, at 2025-12-31$440.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure435Current liabilities, Q1 FY2026, at 2026-03-31$435.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure590Current liabilities, Q2 FY2026, at 2026-06-30$589.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Total liabilities$m999Total liabilities, Q3 FY2023, at 2023-09-30$998.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001558370-23-017983.Report this figure948Total liabilities, FY2023, at 2023-12-31$947.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure892Total liabilities, Q1 FY2024, at 2024-03-31$892.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001558370-24-007601.Report this figure837Total liabilities, Q2 FY2024, at 2024-06-30$836.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001558370-24-011586.Report this figure1,401Total liabilities, Q3 FY2024, at 2024-09-30$1.40bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001558370-24-014858.Report this figure1,435Total liabilities, FY2024, at 2024-12-31$1.43bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure1,397Total liabilities, Q1 FY2025, at 2025-03-31$1.40bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001558370-25-006960.Report this figure1,360Total liabilities, Q2 FY2025, at 2025-06-30$1.36bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001558370-25-010649.Report this figure1,333Total liabilities, Q3 FY2025, at 2025-09-30$1.33bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure1,355Total liabilities, FY2025, at 2025-12-31$1.36bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure1,340Total liabilities, Q1 FY2026, at 2026-03-31$1.34bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure1,824Total liabilities, Q2 FY2026, at 2026-06-30$1.82bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m179Shareholders' equity, Q3 FY2023, at 2023-09-30$178.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001558370-24-014858.Report this figure195Shareholders' equity, FY2023, at 2023-12-31$195.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure222Shareholders' equity, Q1 FY2024, at 2024-03-31$222.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure217Shareholders' equity, Q2 FY2024, at 2024-06-30$216.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure234Shareholders' equity, Q3 FY2024, at 2024-09-30$234.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure229Shareholders' equity, FY2024, at 2024-12-31$228.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure234Shareholders' equity, Q1 FY2025, at 2025-03-31$234.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure232Shareholders' equity, Q2 FY2025, at 2025-06-30$232.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure275Shareholders' equity, Q3 FY2025, at 2025-09-30$274.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001104659-25-107391.Report this figure302Shareholders' equity, FY2025, at 2025-12-31$301.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure312Shareholders' equity, Q1 FY2026, at 2026-03-31$312.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure312Shareholders' equity, Q2 FY2026, at 2026-06-30$311.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure

Cash flow

Operating cash flow$71.3m, Q2 FY2026
Capital expenditure$496.0k, Q2 FY2026
Share repurchases$0, Q2 FY2026
Collegium Pharmaceutical, Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m74.0Operating cash flow, Q3 FY2023, three months to 2023-09-30$74.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001558370-24-014858. Derived: 9-month figure less the 6-month figure.Report this figure73.3Operating cash flow, Q4 FY2023, three months to 2023-12-31$73.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-011992. Derived: 12-month figure less the 9-month figure.Report this figure61.9Operating cash flow, Q1 FY2024, three months to 2024-03-31$61.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001558370-25-006960.Report this figure67.4Operating cash flow, Q2 FY2024, three months to 2024-06-30$67.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001558370-25-010649. Derived: 6-month figure less the 3-month figure.Report this figure(9.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001104659-25-107391. Derived: 9-month figure less the 6-month figure.Report this figure84.6Operating cash flow, Q4 FY2024, three months to 2024-12-31$84.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-011992. Derived: 12-month figure less the 9-month figure.Report this figure55.4Operating cash flow, Q1 FY2025, three months to 2025-03-31$55.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure72.4Operating cash flow, Q2 FY2025, three months to 2025-06-30$72.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-053851. Derived: 6-month figure less the 3-month figure.Report this figure78.4Operating cash flow, Q3 FY2025, three months to 2025-09-30$78.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001104659-25-107391. Derived: 9-month figure less the 6-month figure.Report this figure123Operating cash flow, Q4 FY2025, three months to 2025-12-31$123.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-011992. Derived: 12-month figure less the 9-month figure.Report this figure57.1Operating cash flow, Q1 FY2026, three months to 2026-03-31$57.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure71.3Operating cash flow, Q2 FY2026, three months to 2026-06-30$71.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-053851. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$65.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001558370-24-014858. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$164.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-011992. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$568.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001558370-25-006960.Report this figure0.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$270.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001558370-25-010649. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$244.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001104659-25-107391. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$570.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-011992. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2025, three months to 2025-03-31$798.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$65.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-053851. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$188.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001104659-25-107391. Derived: 9-month figure less the 6-month figure.Report this figure0.7Capital expenditure, Q4 FY2025, three months to 2025-12-31$689.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-011992. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2026, three months to 2026-03-31$270.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure0.5Capital expenditure, Q2 FY2026, three months to 2026-06-30$496.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-053851. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reported25.0Share repurchases, Q4 FY2023, three months to 2023-12-31$25.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001628280-26-011992. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001104659-25-107391. Derived: 9-month figure less the 6-month figure.Report this figure25.0Share repurchases, Q4 FY2024, three months to 2024-12-31$25.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001628280-26-011992. Derived: 12-month figure less the 9-month figure.Report this figurenot reported25.1Share repurchases, Q2 FY2025, three months to 2025-06-30$25.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001104659-25-107391. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001628280-26-011992. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure

Shares

Diluted shares (weighted)32.46m, Q2 FY2026
Collegium Pharmaceutical, Inc, shares, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares42.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3042,058,821 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure41.3Diluted shares (weighted), Q4 FY2023, three months to 2023-12-3141,279,981 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-02-27, accession 0001558370-25-001801.Report this figure41.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3141,438,466 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure40.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3040,383,694 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure40.2Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3040,163,266 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure40.1Diluted shares (weighted), Q4 FY2024, three months to 2024-12-3140,109,649 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure32.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3132,840,153 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure39.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3039,075,703 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure39.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3039,439,890 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure40.1Diluted shares (weighted), Q4 FY2025, three months to 2025-12-3140,076,457 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-02-26, accession 0001628280-26-011992.Report this figure40.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3140,065,665 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628280-26-031697.Report this figure32.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3032,460,783 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure

Shares outstanding: 32.56mShares outstanding, period not labelled, at 2026-07-3132,555,613 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-053851.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.